Britt Meelby Jensen

Britt Meelby Jensen serves as Independent Director of the Company. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed.

Denmark S Tdc Replaces Ceo With Cfo

Sådan lyder vurderingen fra flere analytikere ifølge Finans.

. Furthermore she has in-depth knowledge and understanding of the Novo Group having held various leadership positions between 2002-2013 at Novo Nordisk AS. Fra 2015-2019 var Britt Meelby Jensen administrerende direktør for det børsnoterede biotekselskab Zealand Pharma og hun har tidligere også stået i spidsen for Dako og har haft ledende stillinger i Novo Nordisk. Britt Meelby Jensen var den oplagte kandidat.

1 day agoEffective tomorrow May 20 Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu the firm has announced in a press release. General management in healthcare listed and PE owned companies and. 1 day agoBritt Meelby Jensen is the new CEO of Ambu Photo via Atos Medical Ambu today said it has hired Board Member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez effective tomorrow.

From 2019 to. Developing medicine to make a better life for. Britt Meelby Jensen is Vice President at Agilent Technologies Inc.

On March 1 2022 the former Zealand Pharma CEO steps back from the position in Atos Medical which Coloplast acquired for EUR 22bn in November. His place at the helm will be taken over by Britt Meelby Jensen who has been a board member of Ambu since 2019 a position she leaves as part of the executive reshuffle. After three years at the front of Swedish medtech company Atos Medical Britt Meelby Jensen has set the date for when she will leave the company a press release announces.

Britt Meelby Jensen is on the board of Novo Holdings An and 6 other companies. Hun har en del kredit i markedet bla. She is holding CEO at Atos Medical AB.

Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made good. Den verden Danmark vender tilbage til efter Covid-19 er en radikalt. View Britt Meelby Jensens professional profile on Relationship Science the database of decision makers.

Jensen previously was Chief Executive Officer at Zealand Pharma A Chief Executive Officer at Atos Medical AB Vice President General Manager at Dako Denmark ApS and Chief Executive Officer for. 9 hours agoBritt Meelby Jensen der torsdag blev udpeget til ny adm. Hempel Foundation Hempel Invest AS MB Novo Holdings Member of Novo Advisory Group.

International Marketing Management Copenhagen Business School 2000 MBA Economics Solvay Business. Britt Meelby Jensen has been appointed CEO of the Swedish medtech company Atos Medical. As previously reported Britt Meelby Jensen has left her position as CEO of Zealand Pharma and now it is official that she is the new CEO of Atos Medical.

Britt Meelby Jensen has served as CEO of Atos Medical since 2019 after serving as CEO of Zealand Pharma AS and Dako AS previously. Competencies and special tasks on the Board. Hempel Foundation Hempel Invest AS MB Novo Holdings Member of Novo Advisory Group.

Direktør i Ambu er den rette kandidat til at genskabe tilliden til medicoselskabet efter blandt andet syv nedjusteringer på tre år. Press Releases One News Page. 1 day agoBritt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry.

1 day agoBritt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who. Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. Britt Meelby Jensen har senest været administrerende direktør for Swedish Atos Medical der senere blev solgt til til Coloplast.

Making a difference has always been my motivational force and I also considered going into politics. Britt Meelby Jensen CEO Atos Medical. Britt Meelby Jensen serves as Independent Director of the Company.

The medtech company is based in Malmö Sweden and is focused on laryngectomy care. General management in healthcare listed and PE owned companies and. For sin rolle i Atos.

From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma. Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made. She is holding CEO at Atos Medical AB.

After this interview in December 2018 Britt Meelby Jensen left Zealand Pharma to become the new CEO of Atos Medical. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the. She holds a MSc in International Marketing and Management from Copenhagen Business School and has earned an MBA from Solvay Business School Université Libre de Bruxelles.

Britt Meelby Jensen biography. Today is World Voice Day an annual event dedicated to the celebration of the phenomenon of voice. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022.

Britt has over twenty years of experience from the life science industry pharma diagnostics biotech and medtech. At Atos Medical we are also devoted to voice. Britt Meelby Jensen biography.

Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. Britt Meelby Jensen is a Danish citizen. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale.

The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer. Though Atos Medical is headquartered in Malmo it is a global company with most of the 800 employees spread all over the world so Meelbys new job also involves a lot of traveling something she also looks forward to. Britt Meelby Jensen synes godt om dette.

The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. For example the establishment of a permanent Life Science office referring to the Danish Minister for Industry Business and Financial Affairs is a step in the right direction says Meelby Jensen. Britt Meelby Jensen is a multifaceted woman and as CEO in Zealand Pharma one of few women holding a top position in the 30 publicly listed Danish life science companies MedWatch has reviewed.

Britt Meelby Jensen Steps Down As Ceo Of Atos Medical

Britt Meelby Jensen Crunchbase Person Profile